Sort
16,300 grants matching “fatty liver disease”
Characterizing Alcohol's Effects on Repair of Liver Injury
$981,625Anna Mae Elizabeth Diehl · Duke University · RC2 · FY2010 · AA
Fibrogenesis Targeted Manganese Based MRI Contrast Agent
$980,165Vera Hoffman · Reveal Pharma · R44 · FY2023 · DK
Molecular Basis of Obesity and Obesity-induced Metabolic Diseases
$977,162Haiming Cao · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Breast Cancer Survivors Cardiovascular Risks: Treatment and Behavioral Influences
$976,789Janice K Kiecolt-Glaser · Ohio State University · R01 · FY2016 · CA
A Precision Medicine for Alcohol-Associated Liver Disease
$976,742Wanqing Liu · Genetobe Inc. · UT2 · FY2023 · AA
Understanding and Addressing Cancer Health Disparities in Louisiana
$976,081Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2018 · CA
University of Michigan Center for Gastrointestinal Research
$975,352Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2018 · DK
Clinical Research on Nonalcoholic Fatty Liver Disease
$974,693Rohit Loomba · University Of California, San Diego · U01 · FY2023 · DK
Novel Adipose Targeted Gene Therapy for Lipodystrophy
$974,604Al Hawkins · Zvelt Therapeutics Inc. · R42 · FY2025 · DK
University of Michigan Center for Gastrointestinal Research
$972,429Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2017 · DK
Candidate selection of a LPAR1 antagonist for therapeutic application in NASH
$971,732Fabio Cohen Tucci · Epigen Biosciences, Inc. · R44 · FY2023 · DK
In Vivo Proof of Concept and Target Identification Using Small Molecule Stimulators of Brown Adipogenesis
$969,884Olivier Boss · Energesis Pharmaceuticals, Inc. · R44 · FY2022 · DK
Fibrogenesis Targeted Manganese Based MRI Contrast Agent
$969,394Vera Hoffman · Reveal Pharma · R44 · FY2024 · DK
Mechanisms of Therapy and Model Development in Viral Hepatitis and Liver Diseases
$969,213T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Understanding and Addressing Cancer Health Disparities in Louisiana
$968,492Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2020 · CA
Liver fibrosis cell-based assay platform: integrating patient-derived fibrotic liver ECM with primary stellate cells, Kupffer cells, and hepatocytes to accelerate anti-fibrotic drug development
$967,715John David O'Neill · Xylyx Bio, Inc. · R44 · FY2025 · DK
Hepatocyte Transplantation for Liver Based Metabolic Disease
$965,154Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Mechanisms of Alcoholic Liver Disease
$964,607Bin Gao · National Institute On Alcohol Abuse And Alcoholism · Z01 · FY2008 · AA
Colorado Center for Childhood Liver Disease Research and Education
$964,258Ronald J Sokol · University Of Colorado Denver · U01 · FY2013 · DK
University of Michigan Center for Gastrointestinal Research
$964,011Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2019 · DK
Symptom Distress Mechanisms in Digestive Disorders
$963,315Wendy Henderson · National Institute Of Nursing Research · ZIA · FY2017 · NR
Risk Stratification for and Early Detection of Liver Cancer
$963,046Fasiha Kanwal · Baylor College Of Medicine · U01 · FY2023 · CA
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$962,941Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$962,513Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$962,471Wendy S Post · Johns Hopkins University · R01 · FY2009 · HL